Home
Benjamin L. Palleiko, CEO: KalVista Pharmaceuticals KALV Sell · Filed 24/06/10
Trade details
- Type
- Insider sale
- Amount
- $86,071.45
- Shares · price
- 7,465 sh · $11.53 a share
- Held after
- 224,547 sh
- Person
- Benjamin L. PalleikoCEO
- Trade date
- 24/06/07
- Filed
- 24/06/10
- Days to filing
- 3 days
Sold 3.2% of holdings
- Share of holding sold
- 3.2%
KalVista Pharmaceuticals trades, last 26 weeks
What else happened in KalVista Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/05/08~24/07/07Benjamin L. Palleiko's recent trades
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$292.6K
10,926 sh
$292.6K
Filed 05/26
Traded 05/22
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$30.2K
1,129 sh
$30.2K
Filed 05/19
Traded 05/18
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$88.7K
3,322 sh
$88.7K
Filed 05/13
Traded 05/12
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$193.1K
9,550 sh
$193.1K
Filed 04/20
Traded 04/17
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$107.6K
6,693 sh
$107.6K
Filed 03/10
Traded 03/09